| |
ESA Use N=4,288 |
No ESA Use N=8,245 |
p value |
| Female, (%) |
3,606 (84) |
6,622 (80) |
<0.001 |
| Age (years), (SD) |
42.2 (14.8) |
39.9 (14.9) |
0.85 |
| Race, (%) |
| African American |
1,912 (44) |
4,269 (52) |
<0.001 |
| White |
2,047 (48) |
3,500 (42) |
| Asian |
286 (7) |
397 (5) |
| Native American |
43 (1) |
79 (1) |
| Ethnicity, (%) |
| Hispanic |
637 (15) |
1,394 (17) |
0.003 |
| BMI (kg/m2), (%) |
| Underweight BMI<18 |
360 (8) |
594 (7) |
0.001 |
| 18-25 |
1,890 (44) |
3,470 (42) |
| Overweight/Obesity BMI>25 |
2,038 (48) |
4,181 (51) |
| Serum albumin (mg/dl), (%) |
| ≤2.5 |
988 (23) |
2,864 (35) |
<0.001 |
| 2.6-3.2 |
1,389(32) |
2,745 (33) |
| ≥ 3.3 |
1,911(45) |
2,636 (32) |
| Hemoglobin (mg/dl), (%) |
| ≤8.5 |
1,132 (26) |
2, 926 (36) |
<0.001 |
| 8.6-10 |
1,445 (34) |
2,734 (33) |
| ≥10 |
1,711(40) |
2,585 (31) |
| eGFR (ml/min), (%) |
| ≤5.0 |
926 (22) |
1,898 (23) |
0.003 |
| 5.0-10.0 |
2,400 (56) |
4,352 (53) |
|
| ≥10.0 |
962 (22) |
1,995 (24) |
|
| Medical insurance type, (%) |
| Private |
1,438 (34) |
2,266 (27) |
<0.001 |
| Medicaid |
1,244 (29) |
2,770 (34) |
| No insurance |
247 (6) |
1,068 (13) |
| Medicare |
840 (20) |
1217 (15) |
| Employment at ESRD onset, (%) |
| Employed |
984 (23) |
1,477(18) |
<0.001 |
| Unemployed |
3,304 (77) |
6,768 (82) |
| U.S. region of residence, (%) |
| Northeast |
830 (20) |
1,249 (15) |
<0.001 |
| West |
817 (19) |
1,573 (19) |
| South |
1,723 (41) |
3,721 (40) |
| Midwest |
857 (20) |
1,572 (19) |
| Comorbidities, (%) |
| Hypertension |
3,469 (81) |
6,173(74) |
<0.001 |
| Coronary artery disease |
372 (9) |
473(6) |
<0.001 |
| Peripheral vascular disease |
176 (4) |
241(3) |
<0.001 |
| Diabetes mellitus |
399 (9) |
724(9) |
0.32 |
| Congestive heart failure |
631 (15) |
1,327(16) |
0.04 |
| Chronic obstructive pulmonary disease |
106 (2) |
189(2) |
0.52 |
| Cerebrovascular accident |
251 (39) |
398(5) |
0.01 |
| Current smoking |
153 (4) |
342 (4) |
0.11 |
| IV Drug abuse |
17 (0.4) |
78 (1) |
<0.001 |
| Cancer |
81 (2) |
108 (1) |
0.01 |
*t-test for age and Chi-squared tests for categorical variables comparing LN ESRD
patients receiving vs. not receiving ESA. |
